INTRODUCTION
Bronchiectasis and chronic Obstructive Pulmonary Disease (COPD) share many characteristics, from both the physiopathology 1, 2 and clinical-functional viewpoints. 3, 4 The relationship between them can be summarized in two observations. First, they are both common conditions; especially in older patients it is, therefore, unsurprising to see patients with simultaneous COPD and bronchiectasis. Second, some authors have observed an association between the two, reporting the presence of bronchiectasis in up to 50% of patients with moderate to severe COPD; this suggests that there may be a causal relationship in which COPD is a Bronchiectasis was diagnosed clinically and by high resolution computed tomography (HRCT ) scanning. 6 High resolution CT was performed on a 16-slice helical CT scanner (bright speed Toshiba) with a pitch 0.98, 200-250 mA and 120 kV. Plain scan of the chest was performed from the level of thoracic inlet to just below the inferior pole of the kidney.
Statistical Analysis:
SPSS version 15.0 (SPSS; Chicago, Illinois), was used for the statistical analysis. All data were tabulated as mean and SD in the case of quantitative variables and as absolute numbers and percentages in the case of qualitative variables. The Kolmogorov-Smirnov test was used to analyze the distribution of variables. Patients were assigned to two groups, those with and without bronchiectasis. In the bivariate analysis, variables with a normal distribution were analyzed using the Student t test for independent variables or the Mann-Whitney U test in other cases. risk factor for bronchiectasis. 5 The aim of this study is to identify the factors associated with bronchiectasis, using routine data collected during medical visits from patients diagnosed with moderate or severe COPD.
MATERIALS AND METHODS
This is cross sectional descriptive study. COPD patients admitted and visited chest specialty clinic from September 2016 to September 2017. Patients diagnosed as COPD included and patient diagnosed of previous bronchiectasis were excluded. Permission was obtained from ethical committee and then the study was conducted. A detailed socio-demographic data of every patient presenting with COPD will be collected either from inpatients and chest clinic records. Information was recorded in structured Performa. The demography included age, sex, smoking history & history of exposure to indoor pollution by the use of biomass smoke, visit to health care facility with respiratory symptoms in past, history of previous tuberculosis, use of respiratory medications inhalers, domiciliary oxygen and co-morbid conditions. Detailed evaluation of signs and symptoms, chest radiograph, sputum for gram stain and culture and pulmonary function test findings FEV1/FVC, FEV1 values recorded. Duration of hospital stays will be recorded. Those patients subjected to high resolution CT scan and findings recorded in structured Performa.
COPD was defined as a post bronchodilator ratio of FEV1 /FVC, 70%, adjusted for age and height in a patient with a smoking habit of 10 pack-years and β2-agonist reversibility on predicted FEV1 of, 15% and/or 200 mL. COPD was defined as moderate if the postbronchodilator FEV1 was 70% and severe if the postbronchodilator FEV1 was 50% and very severe if postbronchodilator FEV1 was 30 percent. Bronchiectasis and chronic obstructive pulmonary disease
RESULTS
Total 120 patients of COPD were analyzed among them 67 patients (55.8%) were COPD without bronchiectasis while 53 patients (44.1%) had COPD with bronchiectasis. Forty patients (75.4%) were male and 13 patients (24.5%) were female in COPD with bronchiectasis. Most of the patient COPD with bronchiectasis had moderate to severe airflow limitation. (Table 1 ).
Thirty patients (56.6%) having COPD with bronchiectasis and 18 patients (26.8%) having COPD without bronchiectasis had exacerbation in one year requiring hospitalisation. (Table 1 ) Thirty-six patients (67.9%) had positive sputum culture among patients with COPD with bronchiectasis and 10 patients (14.9%) had positive sputum culture in COPD without bronchiectasis. Most common micro-organisms isolated were Pseudomonas Aeruginosa ( n=20; 55.5%) followed by Klebsiellae Pneumoniae (n-6; 16.6%) among COPD with bronchiectasis group. (Table 2) Among COPD with bronchiectasis patient who had undergone high resolution CT scan chest ( fig. 1A&B ), 43 patients (81.1%) had lower lobe predominance involvement. Bilateral involvement was detected in 30 (56.6%) patients. (Table 3 )
DISCUSSION
The present study examined a well characterized group of hospital outpatients and inpatients with moderate to severe COPD. HRCT scans of the chest were performed on patients in the stable state and the extent of bronchiectasis was quantified. HRCT is now accepted as the imaging modality of choice for the evaluation of bronchiectasis.
Prevalence of bronchiectasis in patient with moderate to severe COPD was observed in 53 patients(44.1%) and it was primarily of cylindrical type(62.2%), having lower lobe predominance 43(81.1%) with similar findings by Patel et al and Martinez M et al. 57.6% in moderate COPD. 7, 8 Other recent studies in patients with COPD with all GOLD stages of disease showed bronchiectasis rate of 27% in ECLIPSE study. 9 The second factor associated with presence of bronchiectasis was positive sputum culture. Thirty six (67.9%) patients of COPD with bronchiectasis had positive sputum culture. The result is similar to study done by Patel etal. 6 He observed that, in 54 patients with moderate to severe COPD, that greater bronchial colonization by potentially pathogenic microorganism (PPM) was associated with the presence of bronchiectasis According to the hypotheses of Cole et al, 10 it is possible that the presence of PPM and concomitant proteolytic products is responsible for triggering the mechanism that generates bronchiectasis, along with the chronic inflammation of the bronchial mucosa secondary to this phenomenon in some patients with COPD.
Patel et al 6 observed that even though the number of exacerbations was not related to bronchiectasis in their study, patients with bronchiectasis did experience longer exacerbations. Our results indicate that the presence of p. aeruginosa could potentially be a marker for bronchiectasis in patients with moderate to severe COPD, similar results was found by Martinez-Garcia et al. 11 The rate of exacerbation requiring hospitalisation in previous year was 56.6% among patient with bronchiectasis with COPD in our study. When bronchiectasis is detected in patient who present with severe functional COPD their prognosis is poorer. Results from patients with moderate to severe COPD, the presence of severe airflow obstruction, the isolation of a PPM in a sputum sample, and the need for at least one hospital admission in the previous year are associated with bronchiectasis. When bronchiectasis is detected in patients who present more severe functional COPD8 with PPMs in the bronchial mucosa and exacerbations particularly serious ones 12 , their prognosis is poorer; this underlines the need for the early identification of the specific phenotype of patients with COPD and bronchiectasis, although further studies are needed to evaluate whether the presence of bronchiectasis worsens the prognosis of patients with COPD.
CONCLUSION
Moderate to severe COPD patient had radiologic prevalance of bronchiectasis resulting in severe airflow limitation, with frequent exacerbation and colonisation with isolation of organisms requiring frequent hospitalisation. This finding will help to identify factors associated with bronchiectasis and to initiate appropriate therapy.
